Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study
- 28 February 2003
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 58 (3), 302-308
- https://doi.org/10.1046/j.1365-2265.2003.01713.x
Abstract
Background Osteoporosis is a frequent, severe and often underestimated consequence of long‐term hypercortisolism, often presenting as bone fracture. objective This prospective study was designed to evaluate whether the abnormalities of bone mass and turnover can be similarly reversed in adolescent and adult patients with Cushing's disease, after correction of hypercortisolism. patients and methods Bone mineral density (BMD) at lumbar spine, serum osteocalcin (OC) and urinary cross‐linked N‐telopeptides of type I collagen (Ntx) levels were measured at diagnosis and 2 years after cure of Cushing's disease (CD) in six patients with childhood‐onset and nine with adulthood‐onset disease. Fifteen age‐, sex‐ and body mass index (BMI)‐matched healthy subjects served as controls. results At diagnosis, BMD Z scores at lumbar spine and OC levels were lower (2·3 ± 0·1 vs.−0·2 ± 0·01; P < 0·01 and 1·6 ± 0·1 vs. 9·6 ± 1·2; P < 0·01 respectively) while urinary Ntx levels were significantly higher (139·9 ± 6·1 vs. 82·0 ± 1·6; P < 0·01) in CD patients than in controls. Among CD patients, similar values of Z scores (−2·4 ± 0·3 vs.−2·2 ± 0·1, P = 0·4) and OC levels (1·7 ± 0·2 vs. 1·6 ± 0·2, P = 0·6) were observed in adolescent and adults patients, whereas urinary Ntx levels were significantly higher (159·7 ± 7·9 vs. 125·9 ± 3·3, P < 0·001) in the former than in the latter group. Two years after remission from hypercortisolism, OC levels (P < 0·001) and lumbar BMD Z scores (−2·2 ± 0·3, P < 0·05; and −1·9 ± 0·2; P < 0·01, respectively) increased significantly, while urinary Ntx levels reduced significantly (P < 0·001) in both adolescent and adult patients. However, biochemical markers and Z scores of BMD remained significantly suppressed compared to controls. conclusions Bone impairment in childhood‐ and adulthood‐onset Cushing's disease patients can be partly, but not completely, reversed 2 years after normalization of cortisol levels. Longer recovery times or additive therapeutic approaches are necessary to maximize peak bone mass in children and restore bone mass in adults with Cushing's disease.Keywords
This publication has 40 references indexed in Scilit:
- Pituitary Adenomas in Children and Adolescents. Clinical Presentation, Diagnosis, and Therapeutic StrategiesThe Endocrinologist, 2000
- Pituitary Tumors in Children and AdolescentsJournal of Clinical Endocrinology & Metabolism, 1999
- Bone Loss Is Correlated to the Severity of Growth Hormone Deficiency in Adult Patients with HypopituitarismJournal of Clinical Endocrinology & Metabolism, 1999
- The Growth Hormone (GH) Response to the Arginine Plus GH-Releasing Hormone Test Is Correlated to the Severity of Lipid Profile Abnormalities in Adult Patients with GH DeficiencyJournal of Clinical Endocrinology & Metabolism, 1999
- The Diagnosis and Differential Diagnosis of Cushing's Syndrome and Pseudo-Cushing's StatesEndocrine Reviews, 1998
- Bone Marker and Bone Density Responses to Dopamine Agonist Therapy in Hyperprolactinemic MalesJournal of Clinical Endocrinology & Metabolism, 1998
- The effect of Cushing's disease on bone mineral density, body composition, growth, and puberty: a report of an identical adolescent twin pairJournal of Clinical Endocrinology & Metabolism, 1996
- Cortisol downregulates osteoblast α1(I) procollagen mRNA by transcriptional and posttranscriptional mechanismsJournal of Cellular Biochemistry, 1995
- Cushing's Syndrome in Children and Adolescents -- Presentation, Diagnosis, and TherapyNew England Journal of Medicine, 1994
- Consequences of childhood-onset growth hormone deficiency for adult bone massJournal of Bone and Mineral Research, 1994